戊酸环戊基酯 | 5451-99-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 戊酸环戊基酯
• 英文名称: cyclopentyl pentanoate
• 英文别名: Cyclopentylvalerate
• CAS: 5451-99-0
• 化学式: C₁₀H₁₈O₂
• 分子量: 170.252
• InChiKey: WODFKKJZIWGYCU-UHFFFAOYSA-N

物化性质

• 沸点：
  214.4±8.0 °C(Predicted)
• 密度：
  0.94±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  12
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2915600000

反应信息

• 作为产物：
  描述：

  戊酸酐 、 环戊醇 反应 10.0h， 生成 戊酸环戊基酯
  参考文献：
  名称：

  在中性条件下使用酯和氢的释放，用钌钳催化的醇酰化醇

  摘要：

  在中性条件下，伴随分子氢的释放，使用未活化的酯，特别是对称酯（例如乙酸乙酯），将仲醇酰化。这种空前的，对环境无害的反应是由脱芳构的钌夹PNN络合物均匀催化的。

  DOI：

  10.1002/adsc.201000663

文献信息

• [EN] NEW PYRAZOLE DERIVATIVES AS ANGIOTENSIN II ANTAGONIST<br/>[FR] NOUVEAUX DERIVES DE PYRAZOLE UTILISES COMME ANTAGONISTES DE L'ANGIOTENSINE II
  申请人：J. URIACH & CIA, S.A.

  公开号：WO1996004273A1

  公开（公告）日：1996-02-15

  (EN) Compounds of general formula (I) and their salts and solvates are angiotensin II receptor antagonists and as such are useful in the treatment of hypertension, congestive heat failure and elevated intraocular pressure. Pharmaceutical compositions including these compounds and processes for their preparation are also provided.(FR) Les composés de formule générale (I) (ainsi que leurs sels et solvates) sont des antagonistes du récepteur de l'angiotensine II et à ce titre sont utiles dans le traitement de l'hypertension, de l'insuffisance cardiaque congestive et de l'hypertension intra-oculaire. Des compositions pharmaceutiques renfermant ces composés et des procédés pour leur préparation sont également décrits.

  (中文) 通式 (I) 及其盐和溶剂化合物是血管紧张素 II 受体拮抗剂，因此在治疗高血压、充血性心力衰竭和眼内压升高方面非常有用。还提供了包括这些化合物的药物组合物和其制备方法。
• USE OF RUTHENIUM COMPLEXES FOR FORMATION AND/OR HYDROGENATION OF AMIDES AND RELATED CARBOXYLIC ACID DERIVATIVES
  申请人：Milstein David

  公开号：US20120253042A1

  公开（公告）日：2012-10-04

  A process for preparing amides by reacting a primary amine and a primary alcohol in the presence of a Ruthenium complex to generate the amide and molecular hydrogen. Primary amines are directly acylated by equimolar amounts of alcohols to produce amides and molecular hydrogen (the only byproduct) in high yields and high turnover numbers. Also disclosed are processes for hydrogenation of amides to alcohols and amines; hydrogenation of organic carbonates to alcohols; hydrogenation of carbamates or urea derivatives to alcohols and amines; amidation of esters; acylation of alcohols using esters; coupling of alcohols with water and a base to form carboxylic acids; dehydrogenation of beta-amino alcohols to form pyrazines and cyclic dipeptides; and dehydrogenation of secondary alcohols to ketones. These reactions are catalyzed by a Ruthenium complex which is based on a dearomatized PNN-type ligand of formula A1 or precursors thereof of formulae A2 or A3.

  一种制备酰胺的方法，包括在Ruthenium配合物的存在下，通过反应一种一级胺和一种一级醇生成酰胺和分子氢。直接用等摩尔量的醇对一级胺进行酰化反应，可以高产率、高周转数地生成酰胺和分子氢（唯一的副产物）。此外，还揭示了将酰胺氢化为醇和胺的方法；将有机碳酸酯氢化为醇的方法；将氨基甲酸酯或尿素衍生物氢化为醇和胺的方法；酯的酰胺化反应；使用酯对醇进行酰化反应；将醇与水和碱偶联形成羧酸；将β-氨基醇脱氢生成吡嗪和环肽；以及将二级醇脱氢生成酮的方法。这些反应由基于A1式或A2式或A3式的去芳香的PNN型配体的Ruthenium配合物催化。
• NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF
  申请人：Milstein David

  公开号：US20130281664A1

  公开（公告）日：2013-10-24

  The present invention relates to novel Ruthenium catalysts and related borohydride complexes, and the use of such catalysts, inter alia, for (1) hydrogenation of amides (including polyamides) to alcohols and amines; (2) preparing amides from alcohols with amines (including the preparation of polyamides (e.g., polypeptides) by reacting dialcohols and diamines and/or by polymerization of amino alcohols); (3) hydrogenation of esters to alcohols (including hydrogenation of cyclic esters (lactones) or cyclic di-esters (di-lactones) or polyesters); (4) hydrogenation of organic carbonates (including polycarbonates) to alcohols and hydrogenation of carbamates (including polycarbamates) or urea derivatives to alcohols and amines; (5) dehydrogenative coupling of alcohols to esters; (6) hydrogenation of secondary alcohols to ketones; (7) amidation of esters (i.e., synthesis of amides from esters and amines); (8) acylation of alcohols using esters; (9) coupling of alcohols with water to form carboxylic acids; and (10) dehydrogenation of beta-amino alcohols to form pyrazines. The present invention further relates to the novel uses of certain pyridine Ruthenium catalysts.

  本发明涉及新型钌催化剂和相关硼氢化物配合物，以及使用这些催化剂，包括：（1）将酰胺（包括聚酰胺）加氢为醇和胺；（2）用胺从醇制备酰胺（包括通过二元醇和二胺反应或氨基醇聚合制备聚酰胺（例如聚肽））；（3）将酯加氢为醇（包括环酯（内酯）或环二酯（二内酯）或聚酯的加氢）；（4）将有机碳酸酯（包括聚碳酸酯）加氢为醇和将氨基甲酸酯（包括聚氨基甲酸酯）或脲衍生物加氢为醇和胺；（5）醇的脱氢缩合成酯；（6）将二级醇加氢为酮；（7）酯的酰胺化（即从酯和胺合成酰胺）；（8）使用酯对醇进行酰化；（9）将醇与水偶联形成羧酸；以及（10）β-氨基醇的脱氢缩合形成吡嗪的新用途。本发明还涉及某些吡啶基钌催化剂的新用途。
• LIQUID COMPOSITION, QUANTUM DOT-CONTAINING FILM, OPTICAL FILM, LUMINESCENT DISPLAY ELEMENT PANEL, AND LUMINESCENT DISPLAY DEVICE
  申请人：TOKYO OHKA KOGYO CO., LTD.

  公开号：EP3812805A1

  公开（公告）日：2021-04-28

  The present invention provides: a liquid composition which can be suitably used for production of an optical film having a favorable fluorescence efficiency and includes quantum dots (A), a quantum dot-containing film obtained by drying and/or curing the liquid composition, an optical film for a light-emitting display element made of the quantum dot-containing film, a light-emitting display element panel including the optical film, and a light-emitting display equipped with the light-emitting display element panel. An ionic liquid (B), and a solvent (S) are incorporated into a liquid composition including quantum dots (A), in which the solvent (S) includes a solvent (S1), the solvent (S1) being a compound having a cyclic skeleton and including a heteroatom other than a hydrogen atom and a carbon atom.

  本发明提供：一种可适当用于生产具有良好荧光效率且包括量子点（A）的光学薄膜的液体组合物、一种通过干燥和/或固化该液体组合物而获得的含量子点薄膜、一种由该含量子点薄膜制成的用于发光显示元件的光学薄膜、一种包括该光学薄膜的发光显示元件面板，以及一种配备有该发光显示元件面板的发光显示器。在包括量子点（A）的液体组合物中加入离子液体（B）和溶剂（S），其中溶剂（S）包括溶剂（S1），溶剂（S1）是具有环状骨架并包括除氢原子和碳原子之外的杂原子的化合物。
• Pandey, Karuna Shanker; Mendki, Murlidhar Jaywantrao; Rao, Karumuru Mallikarjuna, Bioscience, Biotechnology and Biochemistry, 1995, vol. 59, # 4, p. 725 - 727
  作者：Pandey, Karuna Shanker、Mendki, Murlidhar Jaywantrao、Rao, Karumuru Mallikarjuna、Vaidyanathaswamy, Ramamoorthy

  DOI：——

  日期：——